表紙
市場調查報告書

穿戴式皮下藥物輸送

Wearable Subcutaneous Drug Delivery

出版商 Greystone Research Associates 商品編碼 675285
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
穿戴式皮下藥物輸送 Wearable Subcutaneous Drug Delivery
出版日期: 2018年08月13日內容資訊: 英文 90 Pages
簡介

本報告提供穿戴式皮下 (SC) 藥物輸送市場相關調查,主要的市場區隔,市場動態,及市場人口統計,穿戴式藥物遞輸系統的治療需求促進因素,主要的設計要素,材料選擇的問題,技術、市場發展的問題,目前市場情況,市場領導,及今後展望等相關分析。

目錄

摘要整理

  • SC藥物輸送市場區隔動態
  • 托曳開發趨勢
  • 藥物輸送設備的演進
  • SC系統的賦能技術
  • 穿戴式貼片的皮下設計要素
  • 設備/系統架構
  • 產品轉移
  • 數量、粘度
  • 設備電子產品
  • 準確度、劑量的變動
  • 給警報、患者的通知

產品分析、評估

  • Becton Dickinson
  • Omnipod (Insulet)
  • Patch Pumps (Sensile Medical)
  • SmartDose (West
  • Pharmaceuticals)
  • YpsoDose (Ypsomed)
  • Electronic Semi-disposable
  • E3D Patch Pump (Elcam)
  • Mechanical Disposable
  • Enable Injector
  • Captive Devices
  • sc2Wear Infusor (scPharmaceuticals)
  • PatchPump (SteadyMed)
  • Product Specific Devices
  • Neulasta OnPro Injector (Amgen)s

治療市場區隔分析、市場資料

  • 血液因子
  • 心血管
  • 糖尿病
  • 免疫球蛋白
  • 生殖健康
  • 市場要素
  • 法規問題
  • IP、專利
  • 醫療經濟學

企業簡介

目錄
Product Code: PDD363F

As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug marketers. As the administration of injectables moves increasingly from practitioner offices and healthcare facilities to patient homes, decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. A wide spectrum of device attributes, including form factor, device-patient interaction, security and safety, dosing, activation, off-device communication, and drug formulation factors have been incorporated into drug injection devices. Over time, these initiatives will come to be expected by patients in injectable drugs.

Wearable Subcutaneous Drug Delivery - What You Will Learn

  • What wearable subcutaneous injection devices for drug delivery have been approved for marketing, and what are the key market segments, market dynamics and market demographics?
  • What are the therapeutic demand drivers for wearable drug delivery systems?
  • What are the key design factors, material selection issues, technologies and market development issues?
  • What is the market today, who are the leaders, and what will it look like in 2024?
  • Who are the competitors and participants in the wearable subcutaneous drug delivery segment, and what are their product development activities, business strategies, and business alliances and affiliations?
  • What is the importance of pharma-device alliances and design partnerships on wearable injector drug delivery injector drug delivery market?

Table of Contents

  • Executive Summary
  • SC Drug Delivery Market Segment Dynamics
  • Drug Development Trends
  • Drug Delivery Device Evolution
  • SC System Enabling Technologies
  • Wearable Patch Subcutaneous Design Factors
  • Device/System Architecture
  • Product Migration
  • Volumes & Viscosities
  • Device Electronics
  • Accuracy and Dosing Variability
  • Alerts and Patient Notification
  • Product Analysis and Assessments
  • Becton Dickinson
  • Omnipod (Insulet)
  • Patch Pumps (Sensile
  • Medical)
  • SmartDose (West
  • Pharmaceuticals)
  • YpsoDose (Ypsomed)
  • Electronic Semi-disposable
  • E3D Patch Pump (Elcam)
  • Mechanical Disposable
  • Enable Injector
  • Captive Devices
  • sc2Wear Infusor (scPharmaceuticals)
  • PatchPump (SteadyMed)
  • Product Specific Devices
  • Neulasta OnPro Injector (Amgen)s
  • Therapeutic Segment Analysis and Market Data
  • Blood Factors
  • Cardiovascular
  • Diabetes
  • Immunoglobulins
  • Reproductive Health
  • Market Factors
  • Regulatory Issues
  • IP and Patents
  • Healthcare Economics
  • Company Profiles
Back to Top